TUDOR INVESTMENT CORP ET AL - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 140 filers reported holding CARDLYTICS INC in Q2 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.6%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$1,554,465
+578.8%
94,210
+2163.6%
0.02%
+220.0%
Q1 2022$229,000
+13.9%
4,162
+195.2%
0.01%
-16.7%
Q4 2020$201,000
-29.2%
1,410
-65.3%
0.01%
-57.1%
Q2 2020$284,000
+5.6%
4,063
-47.2%
0.01%
-41.7%
Q1 2020$269,000
-85.6%
7,693
-74.2%
0.02%
-71.4%
Q4 2019$1,871,000
+310.3%
29,763
+118.7%
0.08%
+425.0%
Q3 2019$456,00013,6080.02%
Other shareholders
CARDLYTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CAS Investment Partners, LLC 2,821,710$177,373,00029.17%
Antipodean Advisors LLC 656,000$41,236,00023.59%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 272,900$17,154,00012.97%
Oakcliff Capital Partners, LP 281,064$17,668,00010.54%
Polaris Venture Management Co. V, L.L.C. 200,000$12,572,0009.14%
Covey Capital Advisors, LLC 82,947$5,214,0005.63%
683 Capital Management, LLC 575,000$36,145,0004.13%
JS Capital Management LLC 455,000$28,601,0003.30%
CROSSLINK CAPITAL INC 152,086$9,560,0002.17%
Pier Capital, LLC 125,692$7,901,0001.29%
View complete list of CARDLYTICS INC shareholders